Indirect estimation of chronic disease excess mortality.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 20386176)

Published in Epidemiology on May 01, 2010

Authors

Pieter H M van Baal, Rudolf T Hoogenveen, Peter M Engelfriet, Hendriek C Boshuizen

Articles by these authors

Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17

Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med (2007) 3.97

A large outbreak of Legionnaires' disease at a flower show, the Netherlands, 1999. Emerg Infect Dis (2002) 3.24

Consumption of vegetables and fruits and risk of breast cancer. JAMA (2005) 3.02

Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2009) 2.93

Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol (2009) 2.56

Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 2.47

The association between noise exposure and blood pressure and ischemic heart disease: a meta-analysis. Environ Health Perspect (2002) 2.32

Factors of the physical environment associated with walking and bicycling. Med Sci Sports Exerc (2004) 2.21

Potential effect of salt reduction in processed foods on health. Am J Clin Nutr (2013) 2.16

The evaluation of the diet/disease relation in the EPIC study: considerations for the calibration and the disease models. Int J Epidemiol (2008) 2.11

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med (2008) 2.07

Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness. Nicotine Tob Res (2014) 2.03

[Diabetes mellitus in the Netherlands: estimate of the current disease burden and prognosis for 2025]. Ned Tijdschr Geneeskd (2009) 1.95

Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health (2005) 1.93

Aortic root growth in men and women with the Marfan's syndrome. Am J Cardiol (2005) 1.85

Coffee intake and incidence of hypertension. Am J Clin Nutr (2007) 1.80

Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol (2006) 1.65

Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diabetes Care (2007) 1.52

Within- and between-cohort variation in measured macronutrient intakes, taking account of measurement errors, in the European Prospective Investigation into Cancer and Nutrition study. Am J Epidemiol (2004) 1.48

Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer (2003) 1.42

If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. Addiction (2010) 1.42

Re: Twisk and Proper: evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up. J Clin Epidemiol (2005) 1.42

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax (2010) 1.39

Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr (2009) 1.36

Socioeconomic status and stroke incidence in the US elderly: the role of risk factors in the EPESE study. Stroke (2006) 1.36

Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis (2010) 1.35

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr (2006) 1.34

Importance of nondrug costs of intravenous antibiotic therapy. Crit Care (2003) 1.33

Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.32

Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr (2006) 1.27

Age, period and cohort effects on body weight and body mass index in adults: The Doetinchem Cohort Study. Public Health Nutr (2008) 1.23

Cost-effectiveness of lifestyle modification in diabetic patients. Diabetes Care (2009) 1.23

Fruit and vegetable consumption and mortality: European prospective investigation into cancer and nutrition. Am J Epidemiol (2013) 1.22

Selection bias due to non-response in a health survey among patients with rheumatoid arthritis. Eur J Public Health (2002) 1.18

Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis Rheum (2003) 1.17

Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: the Zutphen Study. Tob Control (2007) 1.17

The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: a meta-analysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol (2012) 1.16

Prognostic factors related to recurrent low-back pain and sickness absence. Scand J Work Environ Health (2004) 1.16

Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2004) 1.16

Dietary fiber intake in relation to coronary heart disease and all-cause mortality over 40 y: the Zutphen Study. Am J Clin Nutr (2008) 1.13

Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation. Cost Eff Resour Alloc (2008) 1.13

Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a 'perfect' cost-utility ratio. Health Econ (2007) 1.11

Population trends and inequalities in incidence and short-term outcome of acute myocardial infarction between 1998 and 2007. Int J Cardiol (2012) 1.11

Comparison of tobacco control scenarios: quantifying estimates of long-term health impact using the DYNAMO-HIA modeling tool. PLoS One (2012) 1.11

Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol (2004) 1.10

Quality of rheumatoid arthritis care: the patient's perspective. Int J Qual Health Care (2004) 1.09

Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum (2004) 1.08

The effectiveness of chronic care management for heart failure: meta-regression analyses to explain the heterogeneity in outcomes. Health Serv Res (2012) 1.07

Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Epidemiol (2007) 1.05

Economic evaluation and the postponement of health care costs. Health Econ (2011) 1.04

Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort. Int J Cancer (2006) 1.04

The DYNAMO-HIA model: an efficient implementation of a risk factor/chronic disease Markov model for use in Health Impact Assessment (HIA). Demography (2012) 1.03

To die with or from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail (2011) 1.03

[Diabetes mellitus in the Netherlands: estimate of the current disease burden and prognosis for 2025]. Ned Tijdschr Geneeskd (2009) 1.03

Chronic disease projections in heterogeneous ageing populations: approximating multi-state models of joint distributions by modelling marginal distributions. Math Med Biol (2009) 1.01

Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J (2008) 0.99

Regional differences in healthy life expectancy in The Netherlands. Public Health (2003) 0.99

Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study. Int J Cancer (2007) 0.99

Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases. Value Health (2008) 0.98

the potential of AGE MODE, an age-dependent model, to estimate usual intakes and prevalences of inadequate intakes in a population. J Nutr (2006) 0.96

DYNAMO-HIA--a Dynamic Modeling tool for generic Health Impact Assessments. PLoS One (2012) 0.96

Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings. Health Econ (2011) 0.96

Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 0.95

Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty. BMC Public Health (2011) 0.95

Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study. Clin Gastroenterol Hepatol (2010) 0.93

The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands. Eur J Cardiovasc Prev Rehabil (2009) 0.93

Longitudinal administrative data can be used to examine multimorbidity, provided false discoveries are controlled for. J Clin Epidemiol (2011) 0.93

Ethanol intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Epidemiol (2006) 0.92

Lifestyle intervention: from cost savings to value for money. J Public Health (Oxf) (2009) 0.91

Weight change and incident diabetes: addressing an unresolved issue. Am J Epidemiol (2010) 0.91

Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics (2008) 0.90

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open (2011) 0.90

Poor and good health outcomes in rheumatoid arthritis: the role of comorbidity. J Rheumatol (2006) 0.90

Consumption of meat and fish and risk of lung cancer: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control (2011) 0.89

New smokers and quitters. Transitions in smoking status in a national population. Eur J Public Health (2002) 0.89

Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention. Int J Cancer (2012) 0.89

Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol (2002) 0.88

Unmet demands for health care among patients with rheumatoid arthritis: indications for underuse? Arthritis Rheum (2004) 0.88

Reliability of selected antioxidants and compounds involved in one-carbon metabolism in two Dutch cohorts. Nutr Cancer (2013) 0.88

DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol (2008) 0.88

Increasing tobacco taxes: a cheap tool to increase public health. Health Policy (2006) 0.88

Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data. Popul Health Metr (2011) 0.87

Biochemical markers of aging for longitudinal studies in humans. Epidemiol Rev (2013) 0.87